Verition Fund Management
FENC icon

Verition Fund Management’s Fennec Pharmaceuticals FENC Stock Holding History

Verition Fund Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-10,625
Closed -$53.1K – 3315
2024
Q3 		$53.1K Sell
10,625
-23,113
-69% -$134K ﹤0.01% 3039
2024
Q2 		$206K Buy
+33,738
New +$280K ﹤0.01% 2578

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DG Capital Management New York $326M AUM 39.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Verition Fund Management's FENC Position: Q4 2024 in Review

Verition Fund Management sold out of Fennec Pharmaceuticals (FENC) in Q4 2024, closing a stake of 10,625 shares — an estimated $53.1K sold.

Verition Fund Management first reported a position in FENC in Q2 2024 and held it in 2 quarters. The position peaked at $206K in Q2 2024. 64 funds tracked by Wall St. Rank hold FENC as of Q4 2024.

  • Verition Fund Management reported no remaining Fennec Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
  • Verition Fund Management sold 10,625 Fennec Pharmaceuticals shares in Q4 2024, an estimated $53.1K.
  • Verition Fund Management first reported a position in Fennec Pharmaceuticals in Q2 2024 and held it in 2 quarters.
  • Verition Fund Management's Fennec Pharmaceuticals position peaked at $206K in Q2 2024.
  • 64 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q4 2024.

Based on Verition Fund Management's 13F filing for Q4 2024, filed 14 Feb 2025.